Blog

As evident from our second polling question, ”How far along the road would you say you are for a ‘new’ technological revolution,” the journey to capitalize on the next industrial revolution is just beginning for most participants

This is the second in a three-part blog series on National Pharmacovigilance systems and the role of technology in bridging the gaps in pharmacovigilance of regulatory authorities around the world.

Preparing to meet regulatory and commercial demands of the future requires a progressive, future-proof approach. As the regulatory department prepares for 2020

As evident from our second polling question, ”How far along the road would you say you are for a ‘new’ technological revolution,” the journey to capitalize on the next industrial revolution is just beginning for most participants

ArisGlobal, a leading provider of integrated, cloud-based software solutions for life sciences, announced that Vivek Ahuja, Vice President, Global Pharmacovigilance at ArisGlobal, will present a session at the January 22nd closed-door “Lunch and Learn” series, held at the DIA Pharmacovigilance and Risk Management Conference, scheduled for January 23-25, 2018 in Washington, D.C. “How Automation Can Deliver the Holy Grail in Safety"

Cognitive computing has the potential to revamp the practice of pharmacovigilance, from a tedious, resource-intensive process to a dynamic and efficient practice.

On November 28, 2017, ArisGlobal held a webinar with DIA, “How Automation Can Deliver the Holy Grail in Safety: Achieve Productivity, Compliance and Quality”.  In this webinar, we posed a few questions to the audience, and came up with some interesting information.  We took this and spent some thinking about what this means to our clients in the PV ecosystem.

MIAMI, FLORIDA.  January 11, 2018, 2017 — ArisGlobal, a leading provider of integrated, cloud-based software solutions for life sciences, announced…

Automation technologies are having a major impact on performance and productivity across industries. In regulatory, these technologies also have the potential to reshape many activities across regulatory, leading to significant productivity gains. While there’s a lot of talk about how automation technologies will create new roles with exciting opportunities, the most powerful impact will be on the data quality and the efficiency with which manual tasks will be accomplished.

The constant and critical push to accelerate a product’s time to market continues to push clinical teams to seek solutions that deliver greater efficiencies. But after 20 years of...